Lund-Hansen Torben has filed 5 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 50000 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on August 28, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 28, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Lund-Hansen Torben | SVP & CHIEF TECHNICAL OFFICER | M | Common Stock | 50000 | $4.38 | 131,262.0000 | 44,022,356 | 61.53% | 0.11% |
| Aug. 28, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Lund-Hansen Torben | SVP & CHIEF TECHNICAL OFFICER | S | Common Stock | 50000 | $15.37 | 81,262.0000 | 44,022,356 | 38.09% | 0.11% |
| Aug. 28, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Lund-Hansen Torben | SVP & CHIEF TECHNICAL OFFICER | M | Employee Stock Option (right to buy) | 50000 | $0.00 | 100,000.0000 | 44,022,356 | 33.33% | 0.11% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Lund-Hansen Torben | SVP & CHIEF TECHNICAL OFFICER | A | Common Stock | 17800 | $0.00 | 81,262.0000 | 43,645,388 | 28.05% | 0.04% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Lund-Hansen Torben | SVP & CHIEF TECHNICAL OFFICER | A | Employee Stock Option (right to buy) | 35700 | $0.00 | 35,700.0000 | 43,645,388 | 9999.99% | 0.08% |